By www.ProfitableInvestingTips.com
Takeovers of one company by
another are often touted as a way to
create value due to company
synergies and to reduce cost ...
But do takeovers create value? The
Bayer offer to buy Monsanto for $62
billion brings this thought to mind.
Before We Continue…
Click the links below to get your
FREE training materials.
Free Weekly Investing Webinars
Don’t miss t...
It may or may not succeed as noted
in The Wall Street Journal which says
that Bayer’s Monsanto bid has
fallen flat.
One problem with conglomerates is that
there is something to dislike for
everyone.
Bayer’s bid to buy U.S. seeds and
pesticides company Monsanto risks
suffering the same affliction, at least as
far as its ...
This remains true, even if details
released Monday of the $62 billion offer
including debt look better than expected.
Bayer, whose business spans
pharmaceuticals, crop sciences and
consumer health, seems to be shoveling
as much low-cost deb...
It plans to sell some $15 billion in
discounted equity-hefty but below most
forecasts-after it confirmed its approach
last...
The concern voiced by the journal is
that the benefits to shareholders of a
cash purchase of Monsanto by Bayer
are not suf...
In short this takeover does not create
sufficient value to justify itself in the
near term.
Rather Bayer seems to be thinking
that factors such as the increasing
need for more food from a limited
amount of arable l...
In this case why would Monsanto
shareholders want to sell?
Too Much for Too Little
Current Value
Bloomberg notes that investors are
showing alarm at the final price of
the Bayer bid for Monsanto.
The German company on Monday said it
had told Monsanto it’s willing to pay
$122 a share in cash.
Bayer’s stock dropped as much as 6
percent, extending losses since the
potential deal was first revealed.
Monsanto shares posted muted gains,
rising 4.9 percent to $106.45 in New
York trading, signaling that investors
remain ske...
“I don’t think Monsanto will accept”
Bayer’s proposal, said Andrea Williams,
a fund manager at Royal London Asset
Manageme...
“The danger is that you start then
having discussions about how you are
going to fund a higher offer, because they
are alr...
Bloomberg also notes the likely true
reason behind this takeover attempt,
the need to boost productivity and
feed 10 billi...
If Bayer is going to convince its own
shareholders that having to pay even
more for the deal is a wise decision
they will ...
What Constitutes
Shareholder Value?
According to
Investopedia shareholder value
is the value delivered to shareholders
because of management’s ability to grow
earnings, dividends and share price.
In other words, shareholder value is the
sum of all strategic decisions that affect
the firm’s ability to efficiently incr...
Do takeovers create value? They do
if the end result is growth of
earnings, dividends and share price
for the company that...
In the case of Bayer taking over
Monsanto the seed and crop
protection business will need to
grow more and faster than the...
Próximos SlideShares
Carregando em…5
×

Do Takeovers Create Value?

72 visualizações

Publicada em

http://profitableinvestingtips.com/investing-tips/do-takeovers-create-value

Do Takeovers Create Value?

Takeovers of one company by another are often touted as a way to create value due to company synergies and to reduce cost by eliminating duplicated functions. But do takeovers create value? The Bayer offer to buy Monsanto for $62 billion brings this thought to mind. It may or may not succeed as noted in The Wall Street Journal which says that Bayer’s Monsanto bid has fallen flat.

One problem with conglomerates is that there is something to dislike for everyone. Bayer’s bid to buy U.S. seeds and pesticides company Monsanto risks suffering the same affliction, at least as far as its shareholders are concerned.

This remains true, even if details released Monday of the $62 billion offer including debt look better than expected. Bayer, whose business spans pharmaceuticals, crop sciences and consumer health, seems to be shoveling as much low-cost debt as possible into the all-cash deal, which helped it promise a substantial uplift to earnings and play down the need for asset sales. It plans to sell some $15 billion in discounted equity-hefty but below most forecasts-after it confirmed its approach last week.

The concern voiced by the journal is that the benefits to shareholders of a cash purchase of Monsanto by Bayer are not sufficient to pay cover the cost of acquisition. In short this takeover does not create sufficient value to justify itself in the near term. Rather Bayer seems to be thinking that factors such as the increasing need for more food from a limited amount of arable land will make Monsanto’s seed and herbicide business more and more profitable. In this case why would Monsanto shareholders want to sell?

Too Much for Too Little Current Value

Bloomberg notes that investors are showing alarm at the final price of the Bayer bid for Monsanto.

Publicada em: Notícias e política
0 comentários
0 gostaram
Estatísticas
Notas
  • Seja o primeiro a comentar

  • Seja a primeira pessoa a gostar disto

Sem downloads
Visualizações
Visualizações totais
72
No SlideShare
0
A partir de incorporações
0
Número de incorporações
4
Ações
Compartilhamentos
0
Downloads
3
Comentários
0
Gostaram
0
Incorporações 0
Nenhuma incorporação

Nenhuma nota no slide

Do Takeovers Create Value?

  1. 1. By www.ProfitableInvestingTips.com
  2. 2. Takeovers of one company by another are often touted as a way to create value due to company synergies and to reduce cost by eliminating duplicated functions.
  3. 3. But do takeovers create value? The Bayer offer to buy Monsanto for $62 billion brings this thought to mind.
  4. 4. Before We Continue… Click the links below to get your FREE training materials. Free Weekly Investing Webinars Don’t miss these free training events! http://www.profitableinvestingtips.com/free-webinar Forex Conspiracy Report Read every word of this report! http://www.forexconspiracyreport.com Get 12 Free Japanese Candlestick Videos Includes training for all 12 major candlestick signals. http://www.candlestickforums.com
  5. 5. It may or may not succeed as noted in The Wall Street Journal which says that Bayer’s Monsanto bid has fallen flat.
  6. 6. One problem with conglomerates is that there is something to dislike for everyone.
  7. 7. Bayer’s bid to buy U.S. seeds and pesticides company Monsanto risks suffering the same affliction, at least as far as its shareholders are concerned.
  8. 8. This remains true, even if details released Monday of the $62 billion offer including debt look better than expected.
  9. 9. Bayer, whose business spans pharmaceuticals, crop sciences and consumer health, seems to be shoveling as much low-cost debt as possible into the all-cash deal, which helped it promise a substantial uplift to earnings and play down the need for asset sales.
  10. 10. It plans to sell some $15 billion in discounted equity-hefty but below most forecasts-after it confirmed its approach last week.
  11. 11. The concern voiced by the journal is that the benefits to shareholders of a cash purchase of Monsanto by Bayer are not sufficient to pay cover the cost of acquisition.
  12. 12. In short this takeover does not create sufficient value to justify itself in the near term.
  13. 13. Rather Bayer seems to be thinking that factors such as the increasing need for more food from a limited amount of arable land will make Monsanto’s seed and herbicide business more and more profitable.
  14. 14. In this case why would Monsanto shareholders want to sell?
  15. 15. Too Much for Too Little Current Value
  16. 16. Bloomberg notes that investors are showing alarm at the final price of the Bayer bid for Monsanto.
  17. 17. The German company on Monday said it had told Monsanto it’s willing to pay $122 a share in cash.
  18. 18. Bayer’s stock dropped as much as 6 percent, extending losses since the potential deal was first revealed.
  19. 19. Monsanto shares posted muted gains, rising 4.9 percent to $106.45 in New York trading, signaling that investors remain skeptical about the deal.
  20. 20. “I don’t think Monsanto will accept” Bayer’s proposal, said Andrea Williams, a fund manager at Royal London Asset Management Co.
  21. 21. “The danger is that you start then having discussions about how you are going to fund a higher offer, because they are already stretching the balance sheet.”
  22. 22. Bloomberg also notes the likely true reason behind this takeover attempt, the need to boost productivity and feed 10 billion people by 2050.
  23. 23. If Bayer is going to convince its own shareholders that having to pay even more for the deal is a wise decision they will lead with the argument that Monsanto is a growth engine due to its unique product mix in crop protection and seeds.
  24. 24. What Constitutes Shareholder Value?
  25. 25. According to Investopedia shareholder value
  26. 26. is the value delivered to shareholders because of management’s ability to grow earnings, dividends and share price.
  27. 27. In other words, shareholder value is the sum of all strategic decisions that affect the firm’s ability to efficiently increase the amount of free cash flow over time.
  28. 28. Do takeovers create value? They do if the end result is growth of earnings, dividends and share price for the company that does the taking over.
  29. 29. In the case of Bayer taking over Monsanto the seed and crop protection business will need to grow more and faster than the market is currently assuming based on Monsanto’s share price.

×